Rolf Bjerkvig - Selected Publications#

1. Watson DC, Bayik D, Storevik S, Moreino SS, Sprowls SA, Han J, Augustsson MT, Lauko A, Sravya P, Røsland GV, Troike K, Tronstad KJ, Wang S, Sarnow K, Kay K, Lunavat TR, Silver DJ, Dayal S, Joseph JV, Mulkearns-Hubert E, Ystaas LAR, Deshpande G, Guyon J, Zhou Y, Magaut CR, Seder J, Neises L, Williford SE, Meiser J, Scott AJ, Sajjakulnukit P, Mears JA, Bjerkvig R, Chakraborty A, Daubon T, Cheng F, Lyssiotis CA, Wahl DR, Hjelmeland AB, Hossain JA, Miletic H, Lathia JD. GAP43-dependent mitochondria transfer from astrocytes enhances glioblastoma tumorigenicity. Nat Cancer, 2023 (4(5) 648-664. 2023. IF: 23.1

2. Han MZ, Huang B, Ni SL, Wang J, Li XG, Bjerkvig R. A validated prognostic nomogram for patients with newly diagnosed lower-grade gliomas in a large-scale Asian cohort. Neuro Oncol. 2020 May 15;22(5):729-731. IF. 15.9

3. Han M, Wang S, Fritah S, Wang X, Zhou W, Yang N, Ni S, Huang B, Chen A, Li G, Miletic H, Thorsen F, Bjerkvig R*, Li X, Wang J. Interfering with long non-coding RNA MIR22HG processing inhibits glioblastoma progression through suppression of Wnt/ß-catenin signaling. Brain. 2020 Feb 1;143(2):512-530. (*corresponding author) IF: 14.5

4. Han M, Wang S, Yang N, Wang X, Zhao W, Saed HS, Daubon T, Huang B, Chen A, Li G, Miletic H, Thorsen F, Bjerkvig R*, Li X, Wang J. Therapeutic implications of altered cholesterol homeostasis mediated by loss of CYO46A1 in human glioblastoma. EMBO Mol Med. 2020 Jan 9;12(1):e10924. (*corresponding author) IF: 14

5. Dirkse A, Golebiewska A, Buder T, Nazarov PV, Muller A, Poovathingal S, Brons NHC, Leite S, Sauvageot N, Sarkisjan D, Seyfrid M, Fritah S, Stieber D, Michelucci A, Hertel F, Herold-Mende C, Azuaje F, Skupin A, Bjerkvig R, Deutsch A, Voss-Böhme A, Niclou SP. Stem-cell associated heterogeneity in Glioblastoma results from intrinsic plasticity shaped by the microenvironment. Nat Commun. 2019 Apr 16;10(1):1787. IF:16

6. Daubon T, Léon C, Clarke K, Andrique L, Salabert L, Darbo E, Pineau R, Guérit S, Maitre M, Dedieu S, Jeanne A, Bailly S, Feige J-J, Miletic H, Rossi M, Bello L, Falciani F, Bjerkvig # and Bikfalvi A# (equal contribution) Deciphering the complex role of thrombospondin-1 in glioblastoma development, Nature Commun. 2019 Mar 8; 10(1): 1146. IF:12.1

7. Capper D, Jones DTW, .., Bjerkvig R, Cryan J, Farrell M, .. A, von Deimling A, Pfister SM. DNA methylation-based classification of central nervous system tumours. Nature. 2018 Mar 22;555(7697):469-474. IF: 64

8. Fack F, Tardito S, Hochart G, Oudin A, Zheng L, Fritah S, Golebiewska A, Nazarov PV, Bernard A, Hau AC, Keunen O, Leenders W, Lund-Johansen M, Stauber J, Gottlieb E, Bjerkvig R, Niclou SP. Altered metabolic landscape in IDH-mutant gliomas affects phospholipid, energy, and oxidative stress pathways. EMBO Mol. Med. 2017 Dec;9(12):1681-1695. (IF: 10.2 (Citations: 35) IF: 14
9. Eskilsson E, Røsland GV, Solecki G, Wang Q, Harter PN, Graziani G, Verhaak RGW, Winkler F, Bjerkvig R, Miletic H. EGFR heterogeneity and implications for therapeutic intervention in glioblastoma. Neuro-Oncol. 2018 May 18;20(6):743-752. IF: 15.9

10. Talasila KM, Røsland GV, Hagland HR, Eskilsson E, Flønes IH, Fritah S, Azuaje F, Atai N, Harter PN, Mittelbronn M, Andersen M, Joseph JV, Hossain JA, Vallar L, Noorden CJ, Niclou SP, Thorsen F, Tronstad KJ, Tzoulis C, Bjerkvig R, Miletic H. The angiogenic switch leads to a metabolic shift in human glioblastoma. Neuro- Oncol. 2017 Mar 1;19(3):383-393. IF: 15.9